AOD 9604

Price range: $49.99 through $169.99
1
Lab Tested
Third-party verified
Ships Fast
1-2 business days
Research Use Only
This product is intended for laboratory research purposes only. Not for human or animal consumption.

Description

AOD 9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, supplied as a lyophilized powder for controlled research applications. This short peptide sequence is produced using standardized solid-phase synthesis and is characterized by high-purity analytical validation, including identity and composition profiling suitable for laboratory use. The lyophilized presentation supports stability and consistency across research handling and reconstitution processes. Intended strictly for investigational use in peptide-based research environments. For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.

Storage: Lyophilized material should be stored refrigerated at 2–8°C and protected from light. After reconstitution, store refrigerated at 2–8°C and use within a limited research window under controlled laboratory handling conditions.

Lab Results (COA)

Every batch is tested by an independent third-party laboratory. Download the Certificate of Analysis for complete purity and composition data.

Batch Number: BATCH-2024001
Test Date: Jan 15, 2024
Purity: 99.2%

Properties

CAS Number 221231-10-3
Synonyms HGH Fragment 176-191; Somatotropin Fragment (176-191)
Sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
Molecular Formula C78H123N23O23S2
Molecular Weight 1815.12
Physical Appearance White to off-white lyophilized powder
Terms Laboratory research use only (Ascend Peptides). Not for human, animal, diagnostic, or household use.

2D Structure

Structural representation for reference only

Restricted Access: Research Use Only

Ascend Peptides provides materials for laboratory research purposes only. Before entering this website, you must confirm that you understand and agree to the research-use-only restrictions below.